Burns
Volume 36, Issue 6 , Pages 787-792 , September 2010

Pathway genetic load allows simultaneous evaluation of multiple genetic associations

  • Ryan M. Huebinger

      Affiliations

    • Department of Surgery, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
    • ,
  • Harold R. Garner

      Affiliations

    • Department of Internal Medicine and Biochemistry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
    • ,
  • Robert C. Barber

      Affiliations

    • Department of Surgery, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
    • Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390, USA
    • Corresponding Author InformationCorresponding author at: Department of Surgery, UT Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75390-9160, USA. Tel.: +1 214 648 8043; fax: +1 214 648 8420.

,Accepted 4 February 2010.

References 

  1. Maher B. Personal genomes: the case of the missing heritability. Nature. 2008;456:18–21
  2. Ma L, Runesha HB, Dvorkin D, Garbe JR, Da Y. Parallel and serial computing tools for testing single-locus and epistatic SNP effects of quantitative traits in genome-wide association studies. Bmc Bioinformatics. 2008;9:315
  3. Carlborg O, Haley CS. Epistasis: too often neglected in complex trait studies?. Nat Rev Genet. 2004;5:618–625
  4. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7:781–791
  5. Trichopoulou A, Yiannakouris N, Bamia C, Benetou V, Trichopoulos D, Ordovas JM. Genetic predisposition, nongenetic risk factors, and coronary infarct. Arch Intern Med. 2008;168:891–896
  6. Yiannakouris N, Trichopoulou A, Benetou V, Psaltopoulou T, Ordovas JM, Trichopoulos D. A direct assessment of genetic contribution to the incidence of coronary infarct in the general population Greek EPIC cohort. Eur J Epidemiol. 2006;21:859–867
  7. Horne BD, Anderson JL, Carlquist JF, Muhlestein JB, Renlund DG, Bair TL, et al. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Hum Genet. 2005;69:176–186
  8. Lin X, Song K, Lim N, Yuan X, Johnson T, Abderrahmani A, et al. Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study. Diabetologia. 2009;52:600–608
  9. Lesnick TG, Papapetropoulos S, Mash DC, Ffrench-Mullen J, Shehadeh L, de Andrade M, et al. A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet. 2007;3:e98
  10. van der Net JB, van Etten J, Yazdanpanah M, Dallinga-Thie GM, Kastelein JJ, Defesche JC, et al. Gene-load score of the renin-angiotensin-aldosterone system is associated with coronary heart disease in familial hypercholesterolaemia. Eur Heart J. 2008;29:1370–1376
  11. O’Keefe GE, Hunt JL, Purdue GF. An evaluation of risk factors for mortality after burn trauma and the identification of gender-dependent differences in outcomes. J Am Coll Surg. 2001;192:153–160
  12. Barber RC, O’Keefe GE. Characterization of a single nucleotide polymorphism in the lipopolysaccharide binding protein and its association with sepsis. Am J Respir Crit Care Med. 2003;167:1316–1320
  13. Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet. 2004;41:808–818
  14. Barber RC, Chang LE, Arnoldo BD, Purdue GF, Hunt JL, Horton JW, et al. Innate immunity SNPs are associated with risk for severe sepsis after burn injury. Clin Med Res. 2006;4:250–255
  15. Barber RC, Aragaki CC, Chang LYE, Purdue GF, Hunt JL, Arnoldo BD, et al. CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock. 2007;27:232–237
  16. Gomez R, Cancio LC. Management of burn wounds in the emergency department. Emerg Med Clin North Am. 2007;25:135–146
  17. Rangelfrausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural-history of the systemic inflammatory response syndrome (Sirs)—a prospective study. JAMA-J Am Med Assoc. 1995;273:117–123
  18. Cook R, Cook D, Tilley J, Lee KA, Marshall J. Multiple organ dysfunction: baseline and serial component scores. Crit Care Med. 2001;29:2046–2050
  19. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med. 1995;23:1638–1652
  20. Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O’Keefe GE. Interleukin-6 promoter haplotypes and interleukin-6 cytokine responses. Shock. 2003;20:218–223
  21. Huebinger RM, Chang LY, Liu MM, Minei J, Rivera-Chavez F, Barber RC. IL-10 promoter polymorphisms (-592 and -819) are associated with decreased risk for mortality after burn injury shock, J Burn Care Res 2010, in press.
  22. Kulkarni V, Errami M, Barber R, Garner HR. Exhaustive prediction of disease susceptibility to coding base changes in the human genome. Bmc Bioinformatics. 2008;9:
  23. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45–61
  24. Ioannidis JPA, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306–309
  25. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, et al. Replicating genotype-phenotype associations. Nature. 2007;447:655–660
  26. Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, et al. Lung cancer susceptibility model based on age, family history and genetic variants. PLoS One. 2009;4:e5302
  27. Essers JB, Lee JJ, Kugathasan S, Stevens CR, Grand RJ, Daly MJ. Established genetic risk factors do not distinguish early and later onset Crohn's disease. Inflamm Bowel Dis. 2009;
  28. Zheng SL, Sun J, Wiklund F, Smith S, Stattin P, Li G, et al. Cumulative association of five genetic variants with prostate cancer. N Engl J Med. 2008;358:910–919

PII: S0305-4179(10)00035-5

doi: 10.1016/j.burns.2010.02.001

Burns
Volume 36, Issue 6 , Pages 787-792 , September 2010

Article Tools